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ABSTRACTSConclusion: Wound infection following breast cancer surgery can have
severe consequences by delaying the start of adjuvant chemo-radiotherapy
and affect the outcome of patient. This audit indicates that prophylactic
antibiotics substantially reduce the risk of post-operativewound infections
in breast surgery and thus avoid delay in start of adjuvant treatment or any
additional operation required for deﬁnitive treatment.
0747: ULTRASOUND MARKING OF THE WIRE-TIP PRIOR TO WIRE
GUIDED WIDE LOCAL EXCISION SHOWS PROMISE IN IMPROVING
OUTCOME FOR IMPALPABLE BREAST CANCER
Andy Kordowicz 1, Susie Flexer 1, David Sapherson 2, Gary
Dyke 1. 1Department of Breast Surgery, Harrogate and District Hospital,
Harrogate, North Yorkshire, UK,; 2Department of Radiology, Harrogate and
District Hospital, Harrogate, North Yorkshire, UK
Aim: We examined whether pre-operative ultrasound marking (PUM) of
the wire-tip improved outcome for women undergoing wire-guided wide
local excision (WLE) of impalpable breast cancer.
Methods: Between 01/2010 and 06/2011, 33 women underwent wire-
guidedWLE in our institution. Via a retrospective analysis of case-notes we
identiﬁed patients who had undergone PUM of the wire-tip. Patient age,
tumour characteristics, operating time, mass of specimen excised and
further procedures (cavity-shave) were recorded.
Results: 12 women underwent PUM of the wire-tip (group a), 21 women
did not (group b). Both groups were well matched for age, histological
grade of tumour and tumour size. The median mass of specimen excised
was 48.5g(range 24-92g) for group a and 57g(range 22-140g) for group
b (p¼0.14). Median operating time was 36.5mins(range 19-52mins) for
group a compared to 41mins(range 24-103mins) for group b (p¼0.01).
None of the patients in group a (0%) required a further cavity-shave
compared with 5 of the patients in group b (24%).
Conclusions: PUM of the wire-tip shows promise as an adjunct in wire-
guided WLE of impalpable breast cancer, reducing the mass of specimen
removed (with obvious aesthetic implications), the operating time, and the
number of repeat procedures to which the patient is subjected.
0782: ANALYSIS OF SOCIAL STATUS AND BREAST CANCER PROGNOSIS
USING WELSH INDEX OF MULTIPLE DEPRIVATION AND ACORN
CLASSIFICATION: DOES A GAP EXIST?
Thomas Micic, Rachel Barnes, Kelvin Gomez. Anuerin Bevan Health Board
Trust, Abergavenny, South Wales, UK
Introduction: There has always been an implied association between poor
health and social deprivation. Our study assessed whether a gap in patient
outcome for breast cancer exists between different strata of society within
a geographical region in Wales.
Methods: A retrospective cohort of 745 breast cancer patients was
recruited using cancer registry data from January 2008 to February 2011.
Welsh Index of Multiple Deprivation (WIMD) along with 4 deprivation
categories from the ACORN classiﬁcation based on patient postcodes were
used as a measure of deprivation. Nottingham Prognostic Index (NPI) was
used as a marker of patient outcome.
Results: Analysis of WIMD demonstrated no correlation with NPI
(coefﬁcient: 0.042, p: 0.25). The incidence of breast cancer was highest
(30%) in the least deprived category of patients (20%-26% for the
remaining categories). The mean NPI score was 3.1 for the least deprived
group (3.2 for other categories). 38% of the least deprived patients had an
excellent prognostic outcome (32%-34% for other categories).11% of the
least deprived patients had a poor prognosis (9%-11% for other
categories).
Conclusions: Our results show no statistically signiﬁcant difference in
either the incidence of breast cancer or outcome from treatment of the
disease between different strata of society.
0858: WHAT DO PATIENTS UNDERSTAND ABOUT OF THE ROLE OF
HOSPITAL STAFF AND INVESTIGATIONS IN BREAST CANCER SERVICES?
Rachel L O'Connell, Edward R St John, Nizar Din, Sidonie Hartridge-
Lambert, Omotayo Johnson. Ashford and St Peter's NHS Foundation Trust,
Surrey, UK
Aims: Patients' should be well-informed on the investigations they
undergo and the roles of individual groups of healthcare professionalsinvolved in their care. The aim of this study was to determine the level of
knowledge in patients presenting to a breast unit.
Methods: Awritten questionnaire was given to new patients in the breast
clinic. Questionnaires were reviewed by two independent assessors.
Results: 120 consecutive patients received the questionnaire; 7 declined
or were unable to complete it. Mean age was 46.8 years, 97% (n¼110)
were female and 89% (n¼101) spoke English as their ﬁrst language. 88%
deﬁned ‘surgeon' correctly whereas ‘radiographer' and ‘radiologist' were
correctly deﬁned by only 19% and 29% respectively. 26% correctly
deﬁned ‘pathologist' and 41% ‘oncologist'. Only 39% of patients could
deﬁne ‘mammogram' and 8% ‘ultrasound'. 21% had an understanding of
a ‘multi-disciplinary team meeting'. Younger patients (age<50 years)
had a worse overall understanding than older patients (36% v 41%
correct, p¼0.017)
Conclusion: The majority of breast clinic patients have a poor under-
standing of the investigations they undergo and the role of medical staff
involved in cancer care. Early education is essential, especially in this group
of patients who may require multiple visits and investigations.
0882: THE ROLE OF AXILLARY ULTRASOUND IN EARLY INVASIVE
BREAST CANCER
Liam Convie, Claire Jones, Carrie Mofﬁtt, Mike Reilly, Janne
Bingham. Altnagelvin Hospital, Londonderry, UK
Aim: Axillary node metastases inﬂuence the management of women with
invasive breast cancer. Guidelines recommend axillary ultrasound for all
patients, with ﬁne needle aspiration (FNA) if abnormal. The study aimwas
to assess axillary ultrasound accuracy in a specialist breast centre.
Methods: All cancer patients with early invasive breast cancer, from
August 2010 to August 2011 inclusively, were identiﬁed. Patient demo-
graphics, axillary ultrasound and histology results were obtained. Mann
Whitney U and Fishers Exact tests were used, with a p value of <0.05
considered signiﬁcant.
Results: 197 patients were identiﬁed; 9 were excluded due to incomplete
data. All had axillary ultrasound; 31.0% were abnormal. 64.0% of abnormal
lesions were malignant histologically. Ultrasound sensitivity and
speciﬁcity were 60.9% and 82.5% respectively. Positive and negative
predictive values were 65.0% and 79.8% respectively. Overall accuracy was
75.0%. The median (IQR) proportion of involved nodes was higher in
those with a positive pre-operative ultrasound (50.0%(14.3-85.7%)
vs.17.5%(8.2-42.5%);p¼0.02), although harvested nodes was similar
(17.0(11.0-23.0)vs.14.0(2.7-30.3);p¼0.22). A lower proportion of patients
with micrometastatic disease (35.7%) had a positive ultrasound compared
to macroscopic nodal disease (85.7%;p¼0.004).
Conclusions: Ultrasound accurately assesses axillary lymph node status.
Routine ultrasound should help avoid excessive axillary surgery.
0897: PREDICTING RESPONSE – THE USE OF NEOADJUVANT
CHEMOTHERAPY IN BREAST CANCER A 5 YEAR REVIEW
Eamon Francis, Aoife Lowery, Giueseppe Gullo, John Crown, James
Geraghty, Denis Evoy, Enda W McDermott. St Vincents University
Hospital, Dublin, Ireland
This study aimed to determine the rate of pCR following neoadjuvant
chemotherapy, identify clinicopathologic factors associated with pCR and
validate the efﬁcacy of a published nomogram (Neoadjuvant) (1) in pre-
dicting pCR .
Data was collected on patients with breast cancer treated with neo-
adjuvant chemotherapy at SVUH from July 2006 to July 2011. Patient
demographics, tumour clinicopathologic parameters and chemothera-
peutic regimens were recorded. Response to neoadjuvant chemotherapy
was assessed radiologically and pathologically. Where sufﬁcient data was
available the Neoadjuvant nomogramwas used to calculate the probability
of pCR. Predictive accuracy was assessed by calculating the area under the
receiver operating characteristic (ROC).
89 patients were treated with neoadjuvant chemotherapy during the
study period. pCR was observed in 14%. Estrogen receptor (ER) negativity
and Her2/neu receptor positivity were signiﬁcantly associated with pCR
(p<0.05). All tumours exhibiting a pCR were invasive ductal carcinomas.
No invasive lobular carcinoma exhibited a pCR to neoadjuvant chemo-
therapy. The ROC of the validated nomogram in our breast cancer pop-
ulation revealed a value of 0.87.
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ABSTRACTSClinicopathologic factors including ER and Her2/neu receptor status are
associated with response to neoadjuvant chemotherapy. The Neoadjuvant
nomogrammay be a useful tool in our population of breast cancer patients.
0920: BREAST RADIO-GUIDED OCCULT LESION LOCALISATION (ROLL):
A GOOD ALTERNATIVE TO WIRE-GUIDED LOCALISATION
Han-Sian Lee, Syeda Gilani, Noaman Sarfraz. Warrington & Halton NHS
Hospitals Trust, Merseyside, UK
Aim: To assess the emerging role of radio-guided occult lesion localisation
(ROLL) as a superior alternative to conventional wire-guided localisation
methods in the removal of impalpable breast lesions. This project assessed
the excision margins and re-excision rates of ROLL and compared them to
NICE-based wide local excision (WLE) standards.
Method: Data was collected on a retrospective basis for all patients who
underwent the ROLL-guided removal of screen-detected and incidental
non-palpable breast cancers from July 2009 to July 2011. Benign tumours
and lymphoma(s) excised using ROLL were excluded.
Results: A total of 76 cases were examined. The re-excision rates using the
ROLL technique with a < 2 mm excision margin stood at 7 cases (9.2%)
overall, but this included 4 patients (5.2%) with multi-focal disease
undergoing mastectomy. Only 3 patients (3.9%) required further WLE as
the only procedure. This is well below the NICE guidelines of re-excision
rates for WLE of 13 - 19% of similar margins.
57% of patients had the tumour size up-scaled from the ultrasonic
measurement on ﬁnal histology.
Conclusion: The ROLL technique for the management of non-palpable
breast lesions does effectively show better results as compared to wire-
guided procedures. Further research is necessary to establish the exact role
of ROLL.
0981: WHEN SHOULD WE CONSIDER CONTRALATERAL PROPHYLACTIC
MASTECTOMY IN BRCA1/BRCA2 NEGATIVE FAMILIAL BREAST CANCER
PATIENTS? A STUDY OF HISTOPATHOLOGICAL PATTERNS
Fatima Aloraiﬁ, Trudi McDevitt, Nuala Cody, Marie Meany, Cliona de
Baroid, Rosemarie Kelly, Adrian Bracken, Andrew Green, James
Geraghty. National Centre for Medical Genetics, Dublin, Ireland
Aims: Little is known on the management of BRCA1/BRCA2-negative
familial breast cancer. This study aims to characterize histopathological
data on these patients in order to help in predicting the likelihood of
contralateral breast cancer.
Methods: A 5-year retrospective study was performed on patients referred
to the National Centre for Medical Genetics in Ireland from 2007-2011 for
genetic testing. Clinical and histopathological reports were collected from
high-risk patients (Manchester score >¼16) negative to BRCA1/BRCA2
(N¼179).
Results:42/179 (23%) high-riskBRCA1/BRCA2-negative patients hadbilateral
breast cancer. 22/42 (52%) were moderate to high grade, 20/42 (47%) were
ER+, 6/42 (14%) were HER2+ and 4/42 (10%) were triple negative. Interest-
ingly, only 7/42 (16%) of these tumours were lobular carcinoma.
Conclusion: BRCA1/BRCA2-positive breast cancer patients are considered
high-risk and offered bilateral prophylactic mastectomies. However, these
patients only account for a small proportion of familial breast cancer.
Despite intensive efforts, the discovery of additional breast cancer pre-
disposing genes to account for the large proportion of familial breast
cancer has so far been unsuccessful. Therefore, efforts should be made to
create a scoring system to predict the likelihood of bilateral breast cancer
in this patient group through histopathological data in a larger scale
multinational study.
0992: COULD A PROPORTION OF FAMILIAL BREAST CANCER PATIENTS
TESTING NEGATIVE TO BRCA1 AND BRCA2 IN FACT BE FALSE
NEGATIVES IN THE REPUBLIC OF IRELAND?
Fatima Aloraiﬁ, Trudi McDevitt, Nuala Cody, Marie Meanie, Cliona de
Baroid, Rosemarie Kelly, Adrian Bracken, Andrew Green, James
Geraghty. National Centre for Medical Genetics, Dublin, Ireland
Aim: The National Centre for Medical Genetics (NCMG) provides genetic
testing for familial breast cancer patients throughout Ireland. We per-
formed an audit of BRCA1/BRCA2-negative familial breast cancer patients
and assessed their characteristics.Methods: BRCA1/BRCA2 genetic testing data was collected prospectively
since the NCMG service was ﬁrst introduced in 1998 to present. In addi-
tion, we collected histopathological data on patients from 2007 to 2011
and performed a literature review on BRCA1/BRCA2-positive breast cancer
histological data from previous international reports to compare it with
our Irish cohort.
Results: Since 1998, 618 high-risk affected breast cancer patients were
referred to the NCMG. Only 16% tested positive for BRCA1/BRCA2 germline
mutations. According to the literature, BRCA1-positive tumours tend to be
triple negative and of high grade. In 179 affected patients negative to
BRCA1/BRCA2, 26/179 (15%) were triple negative, 41/179 (23%) were high
grade and 10/179 (6%) were both.
Conclusion: International statistics show that the susceptibility genes
BRCA1 and BRCA2 comprise 25% of familial breast cancer. However, in
Ireland, we show that only 16% are tested positive for BRCA1/BRCA2
mutations at the NCMG. Our next step will be to perform next generation
DNA sequencing on invited participants in order to address this clinically
important question.
1018: ROLE OF MRI IN INVASIVE BREAST CANCER
D. Oweis, P. Rushton, V. Kurup. North Tees and Hartlepool NHS Foundation
Trust, Stockton, UK
Aim: To study the effect of preoperative breast MRI on change of surgical
management in invasive breast cancers.
Methods: Retrospective study of patients(pts) with invasive breast cancer
who underwent a preoperative breast MRI between Jan ‘09 and Dec’11.
Data collected included demographics, radiological investigations, surgical
treatment &histology.
Results: 79pts. with a mean age of 58.6years were included. 24 pts.
underwent breast conservative surgery, 55 pts. had mastectomy. Mean
histological tumour size was 32.5mm. There was a signiﬁcant difference
between MRI size of tumour (mean 36.5mm) and the histological size
(mean 31.3mm) (p¼ 0.19). A signiﬁcant difference was found between the
mammogram(MMG)/Ultrasound(US) size (mean 19.7mm) and the MRI
size (mean 34.5mm). 31.2% had 2cm discrepancy between MMG/US and
MRI and 56.2% had 1cm, 29.2% were multifocal. Discrepancy of 2cm
between MRI and histology was seen in 19.2% and 1cm in 24.4%, 55.9%
were multifocal.
31pts (39.2%) had a change in the operative plan because of a new ipsi-
lateral multifocality (16pts.), contralateral cancer (1pt) or larger cancer
(12pts). Two pts had both a new multifocality and a contralateral breast
cancer. 84% of those had lobular breast cancer.
Conclusion: MRI plays a major role in detecting additional cancer-
s/bigger size and in planning course of treatment especially in lobular
cancers.
1052: WHAT IS THE COST-EFFECTIVENESS FOR MAMMOGRAMS FOR
DETECTING BREAST CANCER RECURRENCE COMPARED WITH THOSE
FOR BREAST CANCER SCREENING?
Lydia Gabriel, Ellena Smith, Sunreet Randhawa, Katy Hogben. Imperial
College NHS Trust, London, UK
Background: There are limited NICE guidelines regarding follow-up
after breast cancer surgery. At Charing Cross, London patients are fol-
lowed up with yearly clinical and mammographic assessment for
5years. The aim of this audit is to determine if annual mammographic
follow-up for breast cancer is cost effective compared to screening
mammography.
Methods: A retrospective audit, for breast patients cancer undergoing
surgery during 2005 at Charing Cross Hospital, London. Data collected
included operative procedures performed, length of follow-up, and
recurrence (method of detection for recurrence) and survival rates. Data
was compared to the pick-up rate NHS Breast Screening Pro-
gramme(NHSBCSP) Audit2008-2009.
Results: 269patients underwent surgery from January-December 2005,
full data collection was possible on 213patients. Average follow up was
4.68years, which equates to 996mammograms(£34860). During this time
there have been 25deaths and 28recurrences. Of the recurrences, 5were
detected by follow up mammogram only. The NHSBCSP detected 17,045
cancers from2008-2009. 199 follow-up mammograms(costing £6965)
